Success Metrics

Clinical Success Rate
100.0%

Based on 9 completed trials

Completion Rate
100%(9/9)
Active Trials
1(9%)
Results Posted
44%(4 trials)

Phase Distribution

Ph phase_2
4
36%
Ph phase_3
6
55%
Ph phase_1
1
9%

Phase Distribution

1

Early Stage

4

Mid Stage

6

Late Stage

Phase Distribution11 total trials
Phase 1Safety & dosage
1(9.1%)
Phase 2Efficacy & side effects
4(36.4%)
Phase 3Large-scale testing
6(54.5%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

9 of 9 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

11

all time

Status Distribution
Active(1)
Completed(9)
Other(1)

Detailed Status

Completed9
unknown1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
1
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (9.1%)
Phase 24 (36.4%)
Phase 36 (54.5%)

Trials by Status

completed982%
unknown19%
recruiting19%

Recent Activity

1 active trials
Showing 5 of 11
completedphase_3

A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair Loss

NCT05910450
recruitingphase_3

Evaluation of Efficacy and Safety of Oral Minoxidil 1 mg in Female Androgenetic Alopecia

NCT05888922
completedphase_3

A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair Loss (SCALP2)

NCT05914805
completedphase_2

A Study of A-101 Solution in Subjects With Common Warts.

NCT02669862
completedphase_2

A Comparison of 188-0551 Solution Versus Vehicle Solution in Subjects With Plaque Psoriasis (Study 203)

NCT03065556
View all 11 trials

Clinical Trials (11)

Showing 11 of 11 trials
NCT05910450Phase 3

A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair Loss

Completed
NCT05888922Phase 3

Evaluation of Efficacy and Safety of Oral Minoxidil 1 mg in Female Androgenetic Alopecia

Recruiting
NCT05914805Phase 3

A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair Loss (SCALP2)

Completed
NCT02669862Phase 2

A Study of A-101 Solution in Subjects With Common Warts.

Completed
NCT03065556Phase 2

A Comparison of 188-0551 Solution Versus Vehicle Solution in Subjects With Plaque Psoriasis (Study 203)

Completed
NCT02667236Phase 3

A Study of A-101 Solution 40% in Subjects With Seborrheic Keratosis.

Completed
NCT02667275Phase 3

A Randomized, Double-Blind, Vehicle-Controlled Study in Subjects With Seborrheic Keratosis

Completed
NCT02644551Phase 2

The Efficacy of CELEXT07 in the Treatment of Toenail Onychomycosis

Unknown
NCT01431820Phase 2

Safety and Efficacy of Luliconazole Solution, 10% in Subjects With Mild to Moderate Onychomycosis

Completed
NCT01841996Phase 1

Pharmacokinetics and Safety Study of ME1111 in Moderate to Severe Onychomycosis Patients

Completed
NCT00907426Phase 3

Safety and Efficacy Study of Bimatoprost to Treat Hypotrichosis of the Eyelashes After Application to the Eyelid Margin

Completed

All 11 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
11